Mark Andrew Crowther


Ontology type: schema:Person     


Person Info

NAME

Mark Andrew

SURNAME

Crowther

Publications in SciGraph latest 50 shown

  • 2021-10-08 Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2020-05-18 Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome in PILOT AND FEASIBILITY STUDIES
  • 2020-05-12 Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide in BMC MEDICAL RESEARCH METHODOLOGY
  • 2020-04-25 A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome in PILOT AND FEASIBILITY STUDIES
  • 2020-04-08 A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2018-12-21 Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study in THROMBOSIS JOURNAL
  • 2018-07-12 Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia in ANNALS OF HEMATOLOGY
  • 2018-06-08 Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies in EUROPEAN JOURNAL OF EPIDEMIOLOGY
  • 2018-03-09 Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2017-06-10 Prevention and Treatment of Thrombotic Antiphospholipid Syndrome in ANTIPHOSPHOLIPID SYNDROME
  • 2017-06-10 15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Treatment Trends Report in ANTIPHOSPHOLIPID SYNDROME
  • 2017-03-13 Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis? in ANNALS OF HEMATOLOGY
  • 2016-06-08 A systematic review of using and reporting survival analyses in acute lymphoblastic leukemia literature in BMC HEMATOLOGY
  • 2016-06 Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials in EUROPEAN JOURNAL OF EPIDEMIOLOGY
  • 2016-03-31 Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population? in CURRENT RHEUMATOLOGY REPORTS
  • 2016-03-05 Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2016-01-16 Guidance for the treatment of deep vein thrombosis and pulmonary embolism in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2015-12-09 Use of Low Molecular Weight Heparins in Patients with Renal Failure; Time to Re-evaluate Our Preconceptions in JOURNAL OF GENERAL INTERNAL MEDICINE
  • 2015-03-05 Aspirin in secondary prevention of recurrent venous thromboembolism in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2015-02-01 The Canadian Choosing Wisely campaign: the Canadian Hematology Society’s top five tests and treatments in ANNALS OF HEMATOLOGY
  • 2014-11-13 Challenges in Measuring Benefit of Clinical Research Training Programs—the ASH Clinical Research Training Institute Example in JOURNAL OF CANCER EDUCATION
  • 2014-04-25 Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit in CRITICAL CARE
  • 2014-02-19 Design of the rivaroxaban for heparin-induced thrombocytopenia study in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2013-08-14 Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis in INTENSIVE CARE MEDICINE
  • 2013-05-09 Reversal of target-specific oral anticoagulants in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2013-04-29 Thrombosis in ESSENTIAL CARDIOLOGY
  • 2013-02-27 Lupus Anticoagulant Testing in HAEMOSTASIS
  • 2013-02-27 Anticardiolipin Antibody and Anti-beta 2 Glycoprotein I Antibody Assays in HAEMOSTASIS
  • 2013-02-26 Proceedings of the 12th national conference on anticoagulant therapy in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2012-05-28 Perioperative Management of the Patient with Immune Thrombocytopenic Purpura De Novo and the Thrombocytopenia of Antiphospholipid Antibody Syndrome in PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATIC DISEASE
  • 2012-03-17 Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20–21, 2011, Salvador, Bahia, Brazil in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2012-02 In medical-surgical ICU patients, major bleeding is common but independent of heparin prophylaxis in CRITICAL CARE
  • 2012-02 Consequences of suspected heparin-induced thrombocytopenia in the ICU in CRITICAL CARE
  • 2011-12-02 Neutralization of Heparin Activity in HEPARIN - A CENTURY OF PROGRESS
  • 2011-11-02 Red blood cell transfusion and increased length of storage are not associated with deep vein thrombosis in medical and surgical critically ill patients: a prospective observational cohort study in CRITICAL CARE
  • 2011-05-06 Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14–16, 2010, São Paulo, Brazil in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2010-06-10 A team-based approach to warfarin management in long term care: A feasibility study of the MEDeINR electronic decision support system in BMC GERIATRICS
  • 2010-01-08 Intensity of Warfarin Coagulation in the Antiphospholipid Syndrome in CURRENT RHEUMATOLOGY REPORTS
  • 2009-03-09 Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2008-07-03 Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review in BMC GERIATRICS
  • 2008-03-13 Geographic variation in the reversal of vitamin K antagonist-associated coagulopathy in CRITICAL CARE
  • 2008-03-04 Detecting myocardial infarction in critical illness using screening troponin measurements and ECG recordings in CRITICAL CARE
  • 2008-03-03 Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors in CRITICAL CARE
  • 2007-12-04 The clinical consequence of subtherapeutic anticoagulation: the low INR study (LINeRS) in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2007-11-15 Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2007-11-13 Re-examining aggressive anticoagulant therapy: the case of acute coronary syndromes in NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE
  • 2007-07 The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Consensus Conference in JOURNAL CANADIEN D'ANESTHÉSIE
  • 2007-03-23 Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2006-12-22 Paper-based dosing algorithms for maintenance of warfarin anticoagulation in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2006-07-25 Measuring the anticoagulant effect of low molecular weight heparins in the critically ill in CRITICAL CARE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.25073.33", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.477522.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.18147.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416739.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413615.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416252.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476875.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418562.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15276.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.163555.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.170205.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.46078.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.55325.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476587.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417238.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7107.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.22072.35", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7177.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417184.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.39381.30", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.28046.38", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.482968.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.59734.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.223827.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416721.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.477947.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410356.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.266842.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412578.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14709.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.17063.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413613.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414019.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413852.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411657.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.55602.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.39382.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415250.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417199.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417581.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413104.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.12136.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418383.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412972.b", 
            "type": "Organization"
          }
        ], 
        "familyName": "Crowther", 
        "givenName": "Mark Andrew", 
        "id": "sg:person.0654435050.12", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0003-4986-4873"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654435050.12", 
          "https://orcid.org/0000-0003-4986-4873"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-01-01T19:59", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/person/person_972.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0654435050.12'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0654435050.12'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0654435050.12'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0654435050.12'


     

    This table displays all metadata directly associated to this object as RDF triples.

    111 TRIPLES      11 PREDICATES      58 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.0654435050.12 schema:affiliation N4f33ea7a1b944bf88d845caff14a9a05
    2 grid-institutes:grid.12136.37
    3 grid-institutes:grid.14709.3b
    4 grid-institutes:grid.15276.37
    5 grid-institutes:grid.163555.1
    6 grid-institutes:grid.170205.1
    7 grid-institutes:grid.17063.33
    8 grid-institutes:grid.18147.3b
    9 grid-institutes:grid.22072.35
    10 grid-institutes:grid.223827.e
    11 grid-institutes:grid.266842.c
    12 grid-institutes:grid.28046.38
    13 grid-institutes:grid.38142.3c
    14 grid-institutes:grid.39381.30
    15 grid-institutes:grid.39382.33
    16 grid-institutes:grid.410356.5
    17 grid-institutes:grid.411657.0
    18 grid-institutes:grid.412578.d
    19 grid-institutes:grid.412972.b
    20 grid-institutes:grid.413104.3
    21 grid-institutes:grid.413613.2
    22 grid-institutes:grid.413615.4
    23 grid-institutes:grid.413852.9
    24 grid-institutes:grid.414019.9
    25 grid-institutes:grid.415250.7
    26 grid-institutes:grid.416252.6
    27 grid-institutes:grid.416721.7
    28 grid-institutes:grid.416739.e
    29 grid-institutes:grid.417184.f
    30 grid-institutes:grid.417199.3
    31 grid-institutes:grid.417238.b
    32 grid-institutes:grid.417581.e
    33 grid-institutes:grid.418383.5
    34 grid-institutes:grid.418562.c
    35 grid-institutes:grid.46078.3d
    36 grid-institutes:grid.476587.f
    37 grid-institutes:grid.476875.f
    38 grid-institutes:grid.477522.1
    39 grid-institutes:grid.477947.e
    40 grid-institutes:grid.482968.9
    41 grid-institutes:grid.55325.34
    42 grid-institutes:grid.55602.34
    43 grid-institutes:grid.59734.3c
    44 grid-institutes:grid.65499.37
    45 grid-institutes:grid.7107.1
    46 grid-institutes:grid.7177.6
    47 schema:familyName Crowther
    48 schema:givenName Mark Andrew
    49 schema:identifier N872fecb43fea499e9b9d07f713412514
    50 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654435050.12
    51 https://orcid.org/0000-0003-4986-4873
    52 schema:sdDatePublished 2022-01-01T19:59
    53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    54 schema:sdPublisher Nee1ba35a62f44f08beeaffef1c0d2437
    55 sgo:license sg:explorer/license/
    56 sgo:sdDataset persons
    57 rdf:type schema:Person
    58 N4f33ea7a1b944bf88d845caff14a9a05 schema:affiliation grid-institutes:grid.25073.33
    59 sgo:isCurrent true
    60 rdf:type schema:OrganizationRole
    61 N872fecb43fea499e9b9d07f713412514 schema:name orcid_id
    62 schema:value 0000-0003-4986-4873
    63 rdf:type schema:PropertyValue
    64 Nee1ba35a62f44f08beeaffef1c0d2437 schema:name Springer Nature - SN SciGraph project
    65 rdf:type schema:Organization
    66 grid-institutes:grid.12136.37 schema:Organization
    67 grid-institutes:grid.14709.3b schema:Organization
    68 grid-institutes:grid.15276.37 schema:Organization
    69 grid-institutes:grid.163555.1 schema:Organization
    70 grid-institutes:grid.170205.1 schema:Organization
    71 grid-institutes:grid.17063.33 schema:Organization
    72 grid-institutes:grid.18147.3b schema:Organization
    73 grid-institutes:grid.22072.35 schema:Organization
    74 grid-institutes:grid.223827.e schema:Organization
    75 grid-institutes:grid.25073.33 schema:Organization
    76 grid-institutes:grid.266842.c schema:Organization
    77 grid-institutes:grid.28046.38 schema:Organization
    78 grid-institutes:grid.38142.3c schema:Organization
    79 grid-institutes:grid.39381.30 schema:Organization
    80 grid-institutes:grid.39382.33 schema:Organization
    81 grid-institutes:grid.410356.5 schema:Organization
    82 grid-institutes:grid.411657.0 schema:Organization
    83 grid-institutes:grid.412578.d schema:Organization
    84 grid-institutes:grid.412972.b schema:Organization
    85 grid-institutes:grid.413104.3 schema:Organization
    86 grid-institutes:grid.413613.2 schema:Organization
    87 grid-institutes:grid.413615.4 schema:Organization
    88 grid-institutes:grid.413852.9 schema:Organization
    89 grid-institutes:grid.414019.9 schema:Organization
    90 grid-institutes:grid.415250.7 schema:Organization
    91 grid-institutes:grid.416252.6 schema:Organization
    92 grid-institutes:grid.416721.7 schema:Organization
    93 grid-institutes:grid.416739.e schema:Organization
    94 grid-institutes:grid.417184.f schema:Organization
    95 grid-institutes:grid.417199.3 schema:Organization
    96 grid-institutes:grid.417238.b schema:Organization
    97 grid-institutes:grid.417581.e schema:Organization
    98 grid-institutes:grid.418383.5 schema:Organization
    99 grid-institutes:grid.418562.c schema:Organization
    100 grid-institutes:grid.46078.3d schema:Organization
    101 grid-institutes:grid.476587.f schema:Organization
    102 grid-institutes:grid.476875.f schema:Organization
    103 grid-institutes:grid.477522.1 schema:Organization
    104 grid-institutes:grid.477947.e schema:Organization
    105 grid-institutes:grid.482968.9 schema:Organization
    106 grid-institutes:grid.55325.34 schema:Organization
    107 grid-institutes:grid.55602.34 schema:Organization
    108 grid-institutes:grid.59734.3c schema:Organization
    109 grid-institutes:grid.65499.37 schema:Organization
    110 grid-institutes:grid.7107.1 schema:Organization
    111 grid-institutes:grid.7177.6 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...